Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06086496 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)

Study acronym: GENCOMX
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary endpoint revised Trial status: Recruiting to Enrolling by Invitation · Interventions: Genoss DES stent (Device) to GENOSS® DES Sirolimus Eluting Coronary Stent System (Device) · Eligibility criteria revised · 5 morev2 Show 8 more changesShow less
    • Trial status: Recruiting to Enrolling by Invitation
    • Interventions: Genoss DES stent (Device) to GENOSS® DES Sirolimus Eluting Coronary Stent System (Device)
    • Eligibility criteria revised
    • Secondary endpoints: 1 to 8
    • Study description expanded, about 7 words
    • Site details revised
    • Study title revised
    • Study arms: 0 to 1

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study, the investigators evaluated the effectiveness and safety of using the GENOSS® DES, which has a biodegradable polymer only on the inner wall of the blood vessel, for patients(all-comers) with coronary artery disease who require percutaneous coronary intervention through stent insertion.
Trial Details
NCT Number NCT06086496
Lead Sponsor Genoss Co., Ltd.
Conditions Coronary Artery Disease, Percutaneous Coronary Intervention
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov